A Microneurography Study of NaV1.8 Inhibition in Healthy Adults

Key Inclusion Criteria: * Body mass index (BMI) of 18.0 to 30.0 kilogram per meter square (kg/m\^2) * A total body weight of more than (\>) 50 kg Key Exclusion Criteria: * History of febrile illness or other acute illness that has not fully resolved within 14 days before study drug dosing * Any condition possibly affecting drug absorption * Any dermatological (generalized) or autoimmune disease that may affect C-nociceptor excitability * Participants with Type 1 or Type 2 diabetes mellitus * Participants who have any 1 of the following criteria in the foot in which microneurography (MNG) will be performed: * Injection of local anesthetics or steroids within 35 days prior to randomization. * Unsuitable anatomy of the superficial peroneal nerve (i.e., nerve cannot be seen or palpated at the dorsum of the foot) * Infection, disease (dermatologic or vascular), ongoing pain, or recent trauma or surgery that may affect study assessments Note: Participants must have 1 foot that does not meet any of the above criteria to be eligible. Other protocol defined Inclusion/Exclusion criteria may apply.